Clinical Science · 2002 · 11 citations · 31 references
MedicineCardiologyMolecular MedicineCardiovascular GeneticsInterventional CardiologyMedical GeneticsBalloon AngioplastyCoronary AngiographyCoronary AngioplastyCoronary Artery DiseaseGenetic RiskReceptor PolymorphismsCoronary Artery Disease GeneticsCoronary Balloon Angioplasty
The present study was designed to prospectively test the hypothesis that gene polymorphisms of the renin-angiotensin system are associated with recurrent restenosis after repeated percutaneous transluminal coronary angioplasty. Five hundred and eleven patients after first successful angioplasty were characterized with respect to the angiotensinogen M235T, angiotensin-converting enzyme insertion/deletion and angiotensin II type 1 receptor A1166C gene polymorphisms. In 164 of these patients repeated angioplasty on a restenotic lesion was performed. After repeated angioplasty, 46 patients had recurrent restenosis as defined by a greater than 50% progression of residual stenosis. In the recurrent restenosis group there was a statistically significant higher percentage of patients receiving cholesterol-lowering drugs compared with the group of patients without recurrent restenosis. The two groups of patients did not differ with respect to procedural and angiographic parameters. There were significantly more carriers of the angiotensinogen 235T allele in the recurrent restenosis group than in the control group without recurrent restenosis. No differences between the two groups were found with respect to the other gene polymorphisms investigated. According to the results of a multifactorial analysis of variance, only the 235T allele of the angiotensinogen gene and not cholesterol drug therapy independently affected the increase of stenosis at follow-up angiography. In conclusion, the angiotensinogen 235T allele may be an independent predictor for recurrent restenosis after repeated angioplasty.
31
Brigitte Rigat, C. Hübert, F Alhenc‐Gelas et al. · Journal of Clinical Investigation · 1990 · 3.8K citations · Full text
Molecular basis of human hypertension: Role of angiotensinogen
Xavier Jeunemaı̂tre, Florent Soubrier, Yuri Kotelevtsev et al. · Cell · 1992 · 1.9K citations
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.
Alain Bonnardeaux, Eleanor Davies, I Féry et al. · Hypertension · 1994 · 730 citations · Full text
Ikuo Inoue, Toshiaki Nakajima, Christopher S. Williams et al. · Journal of Clinical Investigation · 1997 · 550 citations · Full text
Vedapuri Shanmugam, K W Sell, B K Saha · Genome Research · 1993 · 513 citations · Full text